Exchange: NASDAQ·Updated 11:10 AM EST
ABUS logo

ABUS Arbutus Biopharma Corp

$3.89
$0.005
(0.13%)
Today
EarningsNov 16
Mkt Cap$768.65M
Vol304,736.00

About ABUS

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the development of imdusiran (AB-729), proprietary, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic, and AB-101, proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). The company was founded on October 6, 2005 and is headquartered in Warminster, PA.
32

Bearish Sentiment

How do you feel about ABUS?

mj6534
$ABUS god I hate being pessimistic guys but how are we all ok with the crap we’ve dealt with here. I get it we are owed nothing but damn this sucks huge gut punch if I threw my money in MRNA I would’ve made more and yet they are thieves? Makes me sick to my stomach. I’m not f***** leaving I’m just a frustrated investor who feels we have all be done very very very wrong…
20
Jdvm
$ABUS the part c of the ab-101 had 28% of patients showing reduced surface antigen. That's pretty big guys. We didn't expect to see immune reawakening, In immuno exhausted patients from 101 that was 729s job
17
SpaceCityKid
$ABUS The news of the FDA lifting a 3 year freeze on ABUS's Hepatitus B Study is a major development IMO. It removes a major roadblock from inking a partnership deal. It feels like things are about to change for the better.
1
14
hopeful2bright
$ABUS No way the BIG play was for Dutch auction. No way imho. The BIG play comes after Nov hearing, then PFE, then HepB. How would the stock move it it turns out ALL have been cured? Heck, even 50% or 60%. This game is just getting started and 2027 we will know the results imo.
14
mj6534
$ABUS let’s see if crime wins again tomorrow. If it does I’ll gladly join in on a class action with anyone who wants to. Androski and Matt Gline shelled us and screwed us all while lining their own pockets and doing nothing for investor value.
8
DocPharm
$ABUS prediction from a long time ago - AB101 off hold ✅✅ almost on the anniversary of the hold Phase 2b/3 going to be a combo IMDUSIRAN/AB101 combo ??
15
LM_Johanssen
$ABUS Allowing everyone to participate in the Dutch auction instead of just long term holders reeks of malfeasance. I’m considering dumping everything out of spite at this point.
2
9
DocPharm
$ABUS may be on to something here considering it’s just a touch past 30 days (FDA turnaround time) following Whitefort’s conversion from active to passive holder
14
MyBrokenBus
$ABUS It's truly wild that this year, the year we finally won our case against Moderna, THEY are up 520% YTD. We are down 8%. Certainly many other factors, but all the same; not exactly how I saw it playing out in my head all these many years.
14
PsiXPsi
$ABUS I went ahead and sold the rest of my shares. It’s clear that ROIV is just using ABUS to help themselves and institutional holders (saying ABUS is undervalued but selling a third of their position) but hurt retail. I really hope I’m wrong and everyone holding this profits greatly in the future and I lose out, but I don’t trust mgmt to actually do anything good for small shareholders. Good luck all, I hope you win and that I’m wrong!
14
jrothman22
$ABUS All this time for some reason i had no idea that AB 101 was frozen. Alas, the next movement is our court date with the Fed on November 5th. (Remember, remember…) With any luck we get a decent judgment aka government employees are covered, but the rest of American isnt, and we spike back above $6 on our way to $8. And that would be it for me. Need some cashola
13
mj6534
$ABUS We all got bamboozled so bad. Invest in crime and we would be up 1000% lol circus act
9
Abus4ever
$ABUS Technically, the losing party can petition the Supreme Court, but statistically, it is highly improbable the Court will accept it. The Supreme Court denies about 99% of all case requests. With a private settlement already anchoring this specific legal trigger, the Federal Circuit’s decision is practically guaranteed to be the final milestone
12
Kempo73
$ABUS An update from AI ABUS–Moderna appeal date set The Federal Circuit scheduled oral argument in Arbutus Biopharma v. Moderna for Thursday, November 5, 2026. The session begins at 10:00 a.m. Eastern in Courtroom 402; the precise case order or argument time may vary. Why it matters: The appeal will determine whether the government-contractor defense blocks claims covering certain COVID-19 vaccine doses. A full Arbutus/Genevant victory would trigger Moderna’s $1.3 billion contingent settlement payment, although a ruling is not expected on the argument date itself.
12
MyBrokenBus
$ABUS 6/7 weeks red after the dutch auction announcement. I'd hate to see what happens in a world where they aren't adding all this shareholder value.
12
MyBrokenBus
$ABUS considering the meme state of, the entire market, you'd think the shorts here would find a better place to put their money.
11
Kempo73
$ABUS From AI ABUS ownership update — October 7, 2026 Morgan Stanley disclosed beneficial ownership of 18,682,708 Arbutus shares, or 12.2%, as of September 30. That is up from 17,387,398 shares, or 8.8%, reported at June 30—an increase of approximately 1.30 million shares. SEC filing⁠ Why it matters: Morgan Stanley is now one of Arbutus’s largest institutional holders. The percentage increase partly reflects Arbutus’s recent cancellation of 46 million shares, but Morgan Stanley also increased its absolute position. The filing remains passive and expressly says the holdings were not acquired to influence control, so it is not an activist or takeover signal
1
8
NoBSPls
$ABUS It’s becoming clearer every day that none of us “peons” has any idea what the real agenda is here. It looks like a shell company and the market treats it like one. Androsky is a puppet CEO for sure, but what is Gline,s incentive to let his shares erode daily? One obvious reason could be to take control (BO) but he already has de facto control though the BOD. After 6+ years I am disappointed and confused yet stubborn. (Stupid??)
11
renoH4
$ABUS asked ChatGPT: Short-Squeeze Scenarios: $6.X–7: Squeeze begins $8.X–10: Strong short squeeze $12–15: Major squeeze + positive catalyst $20–25: Extreme squeeze $30+: Full-blown melt-up / exceptional catalyst With ~18M shares short, reduced share count and major potential catalysts, ABUS could move very quickly if shorts are forced to cover. A move above $8.X–10 could trigger a self-reinforcing cycle of short covering and momentum buying.
1
8
DocPharm
$ABUS last limit hit today 4.08 Will set a couple sub $4; 3.92 & 3.84 though i don’t think it will get there I have a feeling this will move heavy soon - very sharp decline on the near term usually precedes them
10

Advertisement|Remove ads.